Effect of non-invasive positive pressure ventilation (NIPPV) on mortality in patients with acute cardiogenic pulmonary oedema: a meta-analysis

Lancet
John Victor PeterAndrew D Bersten

Abstract

Non-invasive positive pressure ventilation (NIPPV), using continuous positive airway pressure (CPAP) or bilevel ventilation, has been shown to reduce the need for invasive mechanical ventilation in patients with acute cardiogenic pulmonary oedema. We assessed additional benefits of NIPPV in a meta-analysis. Meta-analysis comparison in acute cardiogenic pulmonary oedema was undertaken to compare (1) CPAP with standard therapy (oxygen by face-mask, diuretics, nitrates, and other supportive care), (2) bilevel ventilation with standard therapy, and (3) bilevel ventilation with CPAP, incorporating randomised controlled trials identified by electronic and hand search (1966-May, 2005). In 23 trials that fulfilled inclusion criteria, we assessed the effect of NIPPV on hospital mortality and mechanical ventilation, estimated as relative risks. CPAP was associated with a significantly lower mortality rate than standard therapy (relative risk 0.59, 95% CI 0.38-0.90, p=0.015). A non-significant trend towards reduced mortality was seen in the comparison between bilevel ventilation and standard therapy (0.63, 0.37-1.10, p=0.11). We recorded no substantial difference in mortality risk between bilevel ventilation and CPAP (p=0.38). The need fo...Continue Reading

References

Feb 1, 1985·The American Journal of Cardiology·J RäsänenA Viitanen
Feb 24, 2001·American Journal of Respiratory and Critical Care Medicine·UNKNOWN Organized jointly by the American Thoracic Society, the European Respiratory Society, the European Society of Intensive Care
Sep 6, 2003·American Journal of Respiratory and Critical Care Medicine·Stefano NavaPaolo Groff
Sep 23, 2003·American Journal of Respiratory and Critical Care Medicine·Miquel FerrerAntoni Torres
Dec 12, 2003·American Journal of Respiratory and Critical Care Medicine·Andrew D Bersten
Mar 3, 2004·Intensive Care Medicine·Erwan L'HerJean-Michel Boles
Dec 16, 2004·Critical Care Medicine·Oleg V Evgenov

❮ Previous
Next ❯

Citations

Sep 23, 2008·Intensive Care Medicine·Roberto CosentiniAnna Maria Brambilla
Nov 26, 2008·Intensive Care Medicine·Giuseppe FotiAntonio Pesenti
Aug 2, 2011·Intensive Care Medicine·Laurent DucrosUNKNOWN CPAP collaborative study group
Apr 11, 2013·Intensive Care Medicine·D ChiumelloD Consonni
Aug 8, 2008·Journal of Anesthesia·Yuko YoshidaAtsuhiro Sakamoto
Mar 12, 2010·Journal of Anesthesia·Masayuki FuruichiAtsuhiro Sakamoto
May 12, 2007·Heart Failure Reviews·Josep Masip
Apr 19, 2007·Heart Failure Reviews·Ramzi ChattiAlexandre Mebazaa
Oct 12, 2012·Internal and Emergency Medicine·Katherine Margaret BergMichael William Donnino
Jan 9, 2009·Ugeskrift for laeger·Ditte-Marie BretlerPeter Riis Hansen
Nov 7, 2008·The New England Journal of Medicine·Robert C McDermid, Sean M Bagshaw
Jul 11, 2008·The New England Journal of Medicine·Alasdair GrayUNKNOWN 3CPO Trialists
Dec 24, 2011·Journal of Aerosol Medicine and Pulmonary Drug Delivery·Rajiv Dhand
Apr 22, 2009·British Journal of Anaesthesia·G W Glover, S J Fletcher
Jul 4, 2006·European Journal of Emergency Medicine : Official Journal of the European Society for Emergency Medicine·Patrick K Plunkett
Sep 25, 2008·Critical Care Medicine·Sean P Keenan
Feb 25, 2009·European Journal of Emergency Medicine : Official Journal of the European Society for Emergency Medicine·Jose M De Miguel-YanesAlmudena Santano-Magariño
Nov 30, 2006·Emergency Medicine Journal : EMJ·J BrowningUNKNOWN 3CPO trial group
Oct 27, 2007·American Journal of Respiratory and Critical Care Medicine·Andrés EstebanUNKNOWN VENTILA Group
Sep 4, 2007·Critical Care : the Official Journal of the Critical Care Forum·Daniela VasquezNiall D Ferguson
Mar 20, 2010·Critical Care : the Official Journal of the Critical Care Forum·Ashar SalmanMichael R Pinsky
Nov 3, 2010·Critical Care : the Official Journal of the Critical Care Forum·Stefano AlibertiRoberto Cosentini
Nov 3, 2010·Circulation Journal : Official Journal of the Japanese Circulation Society·Kirk Kee, Matthew T Naughton
Mar 14, 2007·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·Larry A Allen, Christopher M O'Connor
Nov 7, 2007·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·Oscar PeñuelasAndrés Esteban
Feb 18, 2011·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·Sean P KeenanUNKNOWN Canadian Critical Care Trials Group/Canadian Critical Care Society Noninvasive Ventilation Guidelines Group
Nov 19, 2009·Drug Design, Development and Therapy·Ferenc Follath
Jul 18, 2012·Pediatric Reports·John Scott Baird, Thyyar M Ravindranath
Apr 30, 2011·Clinical Medicine : Journal of the Royal College of Physicians of London·M W Elliott
Feb 7, 2014·Herz·S WalterspacherM Dreher
Mar 7, 2014·Medizinische Klinik, Intensivmedizin und Notfallmedizin·R Doppler
Apr 23, 2014·Journal of Cardiovascular Medicine·Piergiuseppe AgostoniErminio Sisillo
Jan 1, 2014·High Altitude Medicine & Biology·Megan Walmsley
Apr 7, 2012·International Anesthesiology Clinics·Ala Sami Haddadin, Chakib M Ayoub
Jan 2, 2007·Current Opinion in Critical Care·Xavier MonnetChristian Richard
Jan 2, 2007·Current Opinion in Critical Care·François Lellouche
Sep 13, 2008·Current Opinion in Critical Care·Josep Masip
Dec 22, 2011·Current Opinion in Critical Care·Rossella BoldriniStefano Nava
Jun 27, 2012·Current Opinion in Critical Care·Richard L Summers, Sarah Sterling
Jul 23, 2013·Current Cardiology Reports·Athanasia Pataka, Renata L Riha

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.